• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Medicare's meaningful use 3 should focus on measuring improvements to health outcomes, ACP says


Measurements for Medicare's meaningful use stage 3 should focus more on monitoring improvements in patient health than mandating a growing collection of functional measures, according to the American College of Physicians.

Stage 3 meaningful use measures need to focus more on measuring improvements in patient health outcomes rather than a large and growing collection of functional measures, the American College of Physicians (ACP) said in letter to the Health Information Technology Policy Committee (HITPC). The organization's letter comes on the heels of one sent by the American Medical Association to the Office of the National Coordinator for Health Information Technology as well as comments issued by the Medical Group Management Association.

Although praising the HITPC and its Meaningful Use Work Group for their work in developing recommendations for the meaningful use portion of the Electronic Health Record (EHR) Incentive Program, the ACP said that the proposed stage 3 measures appear nearly identical in structure to those of previous stages.

"Stage 3 of meaningful use should encourage patients and practices to innovate, discovering creative ways to use the certified EHR technology they worked so hard to implement in stages 1 and 2 and determining what has the greatest beneficial impact on the healthcare quality and value for patients, families, and communities,” said Michael H. Zaroukian, MD, PhD, FACP, FHIMSS, chairman of the ACP's Medical Informatics Committee and author of the organization’s letter.

"A number of the proposed stage 3 measures necessitate significant increases in clinical documentation, involve new and potentially complex workflows, are likely to be difficult for many eligible professionals to understand and implement, or depend on technologies that are not yet widely deployed or shown to be usable in busy practices,” he added.

The ACP's letter included the following specific concerns and suggestions:

  • Do not introduce new functions without appropriate testing.

  • Choose additional EHR provider note documentation requirements wisely and reduce existing requirements that do not add value.

  • Require usability testing with a specific focus on reducing data collection burdens.

  • Do not add functional requirements that have not been adequately defined.

  • Understand the implications of intensively focusing vendor programming capacity on meaningful use requirements, leaving them with little capacity to optimize the expanded capabilities added to meet stage 1 and 2 certification criteria.

  • Consider the direct and indirect cost implications to eligible professionals when adding new meaningful use requirements.

"We believe the some of the proposed stage 3 requirements are likely to result in new, inefficient workflows and activities that shift physician focus away from the intended goal of patient-centered care and toward an excessive focus data collection for purposes that conflict with the physician’s sense of what is most important for quality, safety, and value,” Dr. Zaroukian said.

The ACP noted its support of the comments offered by HIMSS (Healthcare Information and Management Systems Society) Electronic Health Record Association (EHRA). In particular, ACP supports the following EHRA recommendations:

  • Focus primarily on encouraging and assisting providers to take advantage of the substantial capabilities established in stages 1 and especially stage 2, rather than adding many new meaningful use requirements and product certification criteria.

  • Given recent experience with stage 2, reconsider and extend the timeline for initiating stage 3.

  • Meaningful use and functionality changes for stage 3 should focus on interoperability as a priority area.

  • Invest in quality measure alignment, infrastructure, and standards.

The ACP also asked HITPC to consider previous comments about stage 2 for its final recommendations regarding stage 3 meaningful use measures.

Go back to current issue of eConsult.



Follow Medical Economics on Twitter and like us on Facebook!

Related Content

AMA: 5 problems with meaningful use

Related Videos
Jennifer N. Lee, MD, FAAFP
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health
© National Institute for Occupational Safety and Health